🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07263867
Starting soon Not applicable

Enhanced Ward Rounds for Bowel Preparation Quality in Hospitalized Patients Undergoing Colonoscopy

NCT07263867 · tracked via the Priya Life Science China tracker
Sponsor
LanZhou University
Phase
Not applicable
Started
2026-03-28
Last updated
2026-03-06

Condition(s) studied

ColonoscopyBowel PreparationQuality of Healthcare

Investigational drug(s) / intervention(s)

Enhanced Frequency Ward Rounds with Standardized Intervention PackageStandard Frequency Ward Rounds

Enhanced Frequency Ward Rounds with Standardized Intervention Package: Increase resident physician ward round frequency from 2 to 4 times per day (adding midday 12:00-13:00 and evening 21:00-22:00 rounds). Each ward round includes standardized checklist-based assessment covering medication adherence, dietary compliance, adverse events, and patient understanding. Duration ≥10 minutes per patient. Electronic documentation with time stamps ensures adherence monitoring.

Standard Frequency Ward Rounds: Standard care with resident physician ward rounds twice daily at morning (7:30-9:00) and afternoon (15:00-17:00). Routine clinical assessment and verbal confirmation of preparation protocol. Represents current practice standard.

Study summary

Adequate bowel preparation is critical for successful colonoscopy, yet inadequate preparation remains a significant clinical challenge, occurring in 20-30% of procedures. In hospitalized patients undergoing therapeutic colonoscopy, suboptimal preparation leads to increased costs, prolonged hospital stay, and potential procedure cancellation or rescheduling. Current standard care involves resident ward rounds twice daily.

This cluster-randomized crossover trial aims to evaluate whether increasing the frequency of structured resident ward rounds from 2 to 4 times per day can improve bowel preparation quality in hospitalized patients scheduled for therapeutic colonoscopy. The enhanced ward round intervention includes standardized checklist review, medication verification, dietary compliance confirmation, adverse event screening, and timely intervention when needed.

Three hospital wards will be randomly assigned to different sequences of intervention and control periods using a crossover design with washout periods. The primary outcome is adequate bowel preparation quality assessed by Boston Bowel Preparation Scale (BBPS ≥6 with each segment ≥2), evaluated by blinded endoscopists. Secondary outcomes include procedure quality metrics (cecal intubation rate, examination duration), safety endpoints (electrolyte disturbances, aspiration events), health economics measures (length of stay, total costs), and healthcare worker burden (nursing workload, night-time call frequency).

Subgroup analyses will examine intervention effects across age groups, cognitive function levels, prior colonoscopy experience, and comorbidity burden to identify populations most likely to benefit from enhanced monitoring.

This pragmatic trial addresses a clinically relevant question using a real-world implementation strategy designed to minimize workflow disruption. Results will inform evidence-based policies regarding optimal ward round frequency for colonoscopy preparation in hospital settings.

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
No
Inclusion Criteria: 1. Age ≥18 years 2. Hospitalized patients (inpatients) 3. Scheduled for therapeutic colonoscopy (polypectomy, endoscopic mucosal resection \[EMR\], endoscopic submucosal dissection \[ESD\], or biopsy for diagnosis) 4. Time from admission to scheduled colonoscopy ≥48 hours (allowing adequate preparation time) 5. Patient or legal representative able to provide written informed consent 6. Able to understand and follow bowel preparation instructions (with assistance from caregivers if needed) Exclusion Criteria: 1. Emergency gastrointestinal conditions: bowel obstruction, acute lower gastrointestinal bleeding requiring urgent intervention, suspected or confirmed perforation 2. Emergency or same-day colonoscopy (scheduled \<24 hours after admission) 3. History of total colectomy or current colostomy/ileostomy 4. Severe cognitive impairment (Mini-Cog score 0-1 or MMSE \<18) without available caregiver 5. Severe cardiopulmonary disease: New York Heart Association (NYHA) Class IV heart failure, chronic kidney disease (CKD) stage 4-5 (eGFR \<30 ml/min/1.73m²) unable to tolerate PEG-based preparation 6. Known or suspected pregnancy, currently breastfeeding 7. Previous severe allergic reaction to PEG or bowel preparation agents 8. Current participation in another interventional clinical trial 9. Unable to provide informed consent and no legal representative available 10. Patient or legal representative declines participation

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
The First Hospital of Lanzhou University Lanzhou Gansu

More LanZhou University trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07263867 on ClinicalTrials.gov ↗ ← All trials in China